Piper Sandler Piper Sandler Initiates Coverage of Twist Bioscience, Codexis With Overweight Ratings The investment bank said it believes Twist's high growth is "sustainable" and that synthetic biology is the most exciting market in the life sciences sector. Investment Banks Initiate Coverage of Talis Biomedical With Bullish Outlooks Talis, which went public last month, develops point-of-care infectious disease tests based on its flagship Talis One sample-to-answer platform. Progenity Enters $25M Private Placement The company will issue units representing an aggregate of shares of common stock and warrants to purchase stock shares at an aggregate purchase price of $5.72. Infectious Disease Dx Firm Talis Biomedical Raises $254M in IPO The firm offered 15,870,000 shares of its common stock, including 2,070,000 shares sold pursuant to the full exercise of the underwriters' option. Illumina Upgraded to Overweight by Piper Sandler In a note to investors, Piper Sandler analysts wrote that the upgrade reflects increased confidence in Grail and Illumina's core next-generation sequencing business. Dec 3, 2020 Progenity Prices Separate Public Stock, Private Senior Notes Offerings Sep 25, 2020 Fulgent Inks $125M Equity Distribution Agreement With Piper Sandler Aug 17, 2020 Fulgent Genetics Opens CLIA-Certified Lab in Houston, Raises Revenue Guidance Jul 14, 2020 Piper Sandler Initiates Coverage of Progenity With Overweight Rating Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.